6906
T. Ikawa et al. / Tetrahedron 60 (2004) 6901–6911
1H NMR (CDCl3): d 7.38–7.20 (m, 5H), 6.59 (d, J¼
15.9 Hz, 1H), 6.28 (dt, J¼4.9, 15.9 Hz, 1H), 4.35 (d, J¼
4.9 Hz, 2H), 0.94 (s, 9H), 0.11 (s, 6H). 13C NMR (CDCl3): d
137.1, 129.5, 129.1, 128.4, 127.3, 126.4, 63.9, 26.0, 18.4,
25.2.
NMR (CDCl3): d 137.2, 135.6, 133.6, 129.7, 129.4, 128.7,
128.5, 127.7, 127.3, 126.4, 64.5, 26.8, 19.3.
4.2.6. 1-tert-Butyldimethylsilyloxy-9-decene (1f).16 With
Method A, 9-decen-1-ol (1.56 g, 10.0 mmol), DMAP
(48 mg, 0.40 mmol), Et3N (1.20 g, 12.0 mmol), and tert-
butyldimethylsilyl chloride (1.66 g, 11.0 mmol). The crude
product was purified by column chromatography on silica
gel (eluting with hexane) to give the title compound (1f) as a
colorless oil (1.81 g, 67%).
4.2.2. 1-Triethylsilyloxy-3-phenyl-2-propene (1b).14 With
Method B, cinnamyl alcohol (671 mg, 5.00 mmol), imida-
zole (408 mg, 6.00 mmol), and triethylsilyl chloride
(904 mg, 1.20 mmol). The crude product was purified by
column chromatography on silica gel (eluting with hexane)
to give the title compound (1b) as a colorless oil (717 mg,
93%).
1H NMR (CDCl3): d 5.89–5.73 (m, 1H), 5.30–4.90 (m,
2H), 3.59 (t, J¼5.6 Hz, 2H), 2.07–2.00 (m, 2H), 1.53–1.29
(m, 12H), 0.89 (s, 9H), 0.05 (s, 6H). 13C NMR (CDCl3): d
139.1, 114.1, 63.3, 33.8, 32.9, 29.5, 29.4, 29.1, 29.0, 26.0,
25.8, 18.4, 25.3.
1H NMR (CDCl3): d 7.37 (d, J¼7.5 Hz, 2H), 7.30 (t, J¼
7.5 Hz, 2H), 7.22 (t, J¼7.5 Hz, 1H), 6.60 (d, J¼16.1 Hz,
1H), 6.29 (dt, J¼5.1, 16.1 Hz, 1H), 4.35 (d, J¼5.1 Hz, 2H),
0.99 (t, J¼7.9 Hz, 9H), 0.66 (q, J¼7.9 Hz, 6H).
4.2.7. 4-tert-Butyldimethylsilyloxy-1-butyl acrylate (1g).
With Method A, 4-hydroxybutyl acrylate (2.88 g,
20.0 mmol), DMAP (98 mg, 0.80 mmol), Et3N (2.23 g,
22.0 mmol), and tert-butyldimethylsilyl chloride (3.17g,
21.0 mmol). The crude product was purified by column
chromatography on silica gel (eluting with hexane) to give
the title compound (1g) as a colorless oil (5.04 g, 98%).
4.2.3. 1-Triphenylsilyloxy-3-phenyl-2-propene (1c). With
Method B, cinnamyl alcohol (671 mg, 5.00 mmol), imida-
zole (408 mg, 6.00 mmol), and triphenylsilyl chloride
(1.77 g, 6.00 mmol). The crude product was purified by
column chromatography on silica gel (eluting with hexane)
to give the title compound (1c) as a colorless needles
(1.14 g, 58%).
1H NMR (CDCl3): d 6.40 (dd, J¼1.3, 17.5 Hz, 1H), 6.12
(dd, J¼1.05, 17.5 Hz, 1H), 4.18 (t, J¼6.5 Hz, 2H), 3.65
(t, J¼6.5 Hz, 2H), 1.78–1.71 (m, 2H), 1.64–1.57 (m, 2H),
0.89 (s, 9H), 0.05 (s, 6H). 13C NMR (CDCl3): d 166.0,
130.2, 128.6, 64.3, 62.4, 29.1, 25.8, 25.2, 18.2, 25.5. MS
(EI) m/z 201 (Mþ2C4H9, 10%), 129 (100), 75 (15), 55 (35).
HRMS (EI) calcd for C9H17O3Si (Mþ2C4H9) 201.0947.
Found 201.0939.
1H NMR (CDCl3): d 7.67 (dd, J¼1.47, 7.82 Hz, 6H), 7.48–
7.19 (m, 14H), 6.59 (d, J¼15.9 Hz, 1H), 6.29 (dt, J¼5.1,
15.9 Hz, 1H), 4.51 (dd, J¼1.47, 4.63 Hz, 2H). 13C NMR
(CDCl3): d 136.9, 135.4, 134.0, 130.1, 130.1, 128.4, 128.2,
127.9, 127.3, 126.4, 64.5. MS (EI) m/z 392 (Mþ, 24%), 314
(22), 260 (22), 259 (100), 236 (23), 199 (45), 181 (22), 117
(16), 115 (15). Anal. Calcd for C27H24OSi: C, 82.61; H,
6.16. Found C, 82.49; H, 6.19.
4.2.8. 1-tert-Butyldimethylsilyloxy-2-(2-propenyl)ben-
zene (1h).17 With Method B, 2-allylphenol (1.34 g,
10.0 mmol), imidazole (1.36 g, 20.0 mmol), and tert-
butyldimethylsilyl chloride (1.80 g, 12.0 mmol). The
crude product was purified by column chromatography on
silica gel (eluting with hexane) to give the title compound
(1h) as a colorless oil (1.89 g, 76%).
4.2.4. 1-Triisopropylsilyloxy-3-phenyl-2-propene (1d).
With Method B, cinnamyl alcohol (671 mg, 5.00 mmol),
imidazole (408 mg, 6.00 mmol), and triisopropylsilyl
chloride (1.16 g, 6.00 mmol). The crude product was
purified by column chromatography on silica gel (eluting
with hexane) to give the title compound (1d) as a colorless
oil (1.22 g, 85%).
1H NMR (CDCl3): d 7.13 (d, J¼7.6 Hz, 1H), 7.08 (t,
J¼7.6 Hz, 1H), 6.89 (t, J¼7.6 Hz, 1H), 6.78 (d, J¼7.6 Hz,
1H), 6.02–5.92 (m, 1H), 5.05 (s, 1H), 5.02 (d, J¼3.9 Hz,
1H), 3.37 (d, J¼6.8 Hz, 2H), 1.01 (s, 9H), 0.23 (s, 6H). 13C
NMR (CDCl3): d 153.4, 137.0, 130.7, 130.2, 127.0, 121.1,
118.4, 115.4, 34.4, 25.8, 18.3, 24.1.
1H NMR (CDCl3): d 7.42–7.24 (m, 5H), 6.67 (d, J¼
15.6 Hz, 1H), 6.34 (dt, J¼15.6, 4.9 Hz, 1H), 4.46 (dd,
J¼4.9, 1.5 Hz, 2H), 1.21–1.12 (m, 3H and 18H). 13C NMR
(CDCl3): d 137.3, 129.4, 129.0, 128.5, 127.2, 126.4, 63.9,
18.0, 12.1. MS (EI) m/z 290.5 (Mþ, 20%), 248 (21), 247
(100), 117 (47), 115 (15). HRMS (EI) calcd for C18H30OSi
(Mþ) 290.2066. Found 290.2057.
4.2.9. 1-Triethylsilyloxy-9-decene (1i). With Method A,
9-decene-1-ol (753 mg, 4.80 mmol), DMAP (110 mg,
0.90 mmol), triethylsilyl chloride (1.00 g, 7.23 mmol) in
pyridine (10 mL) used as a solvent instead of CH2Cl2. The
crude product was purified by column chromatography on
silica gel (eluting with hexane) to give the title compound
(1i) as a colorless oil (1.11 g, 85%).
4.2.5. 1-tert-Butyldiphenylsilyloxy-3-phenyl-2-propene
(1e).15 With Method B, cinnamyl alcohol (335 mg,
2.50 mmol), imidazole (204 mg, 3.00 mmol), and tert-
butyldiphenylsilyl chloride (825 mg, 3.00 mmol). The
crude product was purified by column chromatography on
silica gel (eluting with hexane) to give the title compound
(1e) as a colorless oil (799 mg, 86%).
1H NMR (CDCl3): d 5.86–5.76 (m, 1H), 4.99 (dd, J¼2.0,
17.1 Hz, 1H), 4.92 (dd, J¼2.0, 10.3 Hz, 1H), 3.59 (t, J¼
6.8 Hz, 2H), 2.03 (q, J¼7.0 Hz, 2H), 1.55–1.51 (m, 2H),
1.37–1.29 (m, 10H), 0.95 (t, J¼8.0 Hz, 9H), 0.60 (q, J¼
8.0 Hz, 6H). 13C NMR (CDCl3): d 139.2, 114.1, 63.0, 33.8,
32.9, 29.5, 29.4, 29.1, 28.9, 25.8, 6.8, 4.5. MS (EI) m/z 271
1H NMR (CDCl3): d 7.71 (dd, J¼1.5, 7.8 Hz, 4H), 7.45–
7.20 (m, 11H), 6.64 (d, J¼15.6 Hz, 1H), 6.28 (dt, J¼4.9,
15.6 Hz, 1H), 4.38 (d, J¼4.9 Hz, 2H), 1.09 (s, 9H). 13C